Full Text View
Tabular View
No Study Results Posted
Related Studies
Renal Effects of Levosimendan in Patients Admitted With Acute Decompensated Heart Failure
This study is not yet open for participant recruitment.
Study NCT00527059   Information provided by University of Roma La Sapienza
First Received: September 7, 2007   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Heart Failure
Renal Insufficiency
More general conditions related to this trial
Cardiovascular Diseases
Heart Diseases
Kidney Diseases
Urologic Diseases
Interventions listed in this trial
spironolactone, beta-blockers,ecc
Additional drug interventions recognized in this trial
Adrenergic beta-Antagonists
Simendan
Spironolactone
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Antagonists
Aldosterone Antagonists
Anti-Arrhythmia Agents
Cardiotonic Agents
Cardiovascular Agents
Diuretics
Enzyme Inhibitors
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Natriuretic Agents
Neurotransmitter Agents
Pharmacologic Actions
Phosphodiesterase Inhibitors
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
University of Roma La Sapienza


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services